Aceso Life Science Group Ltd
HKEX:474
Income Statement
Earnings Waterfall
Aceso Life Science Group Ltd
Revenue
|
264m
HKD
|
Cost of Revenue
|
-141m
HKD
|
Gross Profit
|
123m
HKD
|
Operating Expenses
|
-111m
HKD
|
Operating Income
|
12m
HKD
|
Other Expenses
|
-432m
HKD
|
Net Income
|
-420m
HKD
|
Income Statement
Aceso Life Science Group Ltd
Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
320
N/A
|
282
-12%
|
296
+5%
|
359
+22%
|
346
-4%
|
0
N/A
|
318
N/A
|
355
+11%
|
315
-11%
|
347
+10%
|
312
-10%
|
264
-15%
|
|
Gross Profit | |||||||||||||
Cost of Revenue |
(166)
|
(132)
|
(129)
|
(145)
|
(133)
|
0
|
(135)
|
(175)
|
(153)
|
(206)
|
(171)
|
(141)
|
|
Gross Profit |
153
N/A
|
149
-3%
|
167
+11%
|
214
+28%
|
213
0%
|
0
N/A
|
183
N/A
|
180
-2%
|
162
-10%
|
141
-13%
|
141
+0%
|
123
-13%
|
|
Operating Income | |||||||||||||
Operating Expenses |
(169)
|
(595)
|
(91)
|
291
|
(138)
|
0
|
(140)
|
(273)
|
(117)
|
19
|
(62)
|
(111)
|
|
Selling, General & Administrative |
(219)
|
(203)
|
(189)
|
(213)
|
(204)
|
0
|
(171)
|
(210)
|
(153)
|
(180)
|
(126)
|
(123)
|
|
Other Operating Expenses |
50
|
(392)
|
97
|
504
|
66
|
0
|
31
|
(63)
|
36
|
198
|
64
|
12
|
|
Operating Income |
(16)
N/A
|
(446)
-2 686%
|
75
N/A
|
505
+571%
|
75
-85%
|
0
N/A
|
43
N/A
|
(93)
N/A
|
45
N/A
|
159
+253%
|
79
-50%
|
12
-85%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
(480)
|
338
|
7
|
(518)
|
(13)
|
0
|
169
|
0
|
(623)
|
(735)
|
(408)
|
(582)
|
|
Non-Reccuring Items |
15
|
4
|
(349)
|
(626)
|
(385)
|
0
|
(195)
|
0
|
23
|
135
|
116
|
101
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(196)
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
82
|
0
|
(236)
|
0
|
0
|
|
Pre-Tax Income |
(481)
N/A
|
(104)
+78%
|
(267)
-157%
|
(638)
-139%
|
(323)
+49%
|
0
N/A
|
17
N/A
|
(207)
N/A
|
(555)
-168%
|
(677)
-22%
|
(213)
+69%
|
(469)
-120%
|
|
Net Income | |||||||||||||
Tax Provision |
64
|
46
|
(11)
|
(32)
|
(25)
|
0
|
(38)
|
(47)
|
(41)
|
(26)
|
5
|
15
|
|
Income from Continuing Operations |
(417)
|
(58)
|
(278)
|
(671)
|
(348)
|
0
|
(21)
|
(254)
|
(596)
|
(703)
|
(208)
|
(454)
|
|
Income to Minority Interest |
36
|
18
|
(6)
|
0
|
(28)
|
0
|
(4)
|
821
|
226
|
957
|
(56)
|
34
|
|
Net Income (Common) |
(381)
N/A
|
(40)
+89%
|
(284)
-601%
|
(670)
-136%
|
(376)
+44%
|
0
N/A
|
(25)
N/A
|
(254)
-916%
|
(370)
-46%
|
(338)
+9%
|
(264)
+22%
|
(420)
-59%
|
|
EPS (Diluted) |
-0.08
N/A
|
-0.01
+88%
|
-0.05
-400%
|
-0.11
-120%
|
-0.06
+45%
|
0
N/A
|
0
N/A
|
-0.02
N/A
|
-0.05
-150%
|
-0.07
-40%
|
-0.04
+43%
|
-0.06
-50%
|